Innovating Complex Therapeutics at Europe’s Premier Platform for Peptide and Oligonucleotide Thought Leadership
As the biopharmaceutical landscape evolves, the development of peptide and oligonucleotide therapeutics is gaining unprecedented momentum. These complex molecules are at the forefront of the next generation of targeted therapies, offering promising treatments for a variety of diseases, including cancer, cardiovascular conditions, and rare genetic disorders. However, the path from discovery to market for these therapeutics is fraught with unique challenges, particularly in terms of synthesis, scalability, regulatory approval, and commercialization.
Peptides & Oligonucleotides Europe 2025 is designed to address these specific challenges in a focused and strategic manner. Unlike larger, more generalized conferences, this event will offer a deeply specialized forum that caters exclusively to senior leaders, top scientists, and decision-makers who are driving innovation in this niche yet rapidly growing sector. The event will emphasize high-level discussions on the most pressing issues facing the industry, such as optimizing the synthesis of complex molecules, navigating the intricate regulatory landscape, and developing effective strategies for commercial scale-up.
Limited Super
GBP 850
*END-USER PRICING IS APPLICABLE to :
Company Profiles: Local Biopharma and BIG Pharma, Europe Academic & Research Institutes
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
Limited Super
GBP 2,050
*SOLUTION PROVIDER PRICING IS APPLICABLE to
Company Profile: Service & Solution Providers, Europe/UK and International biopharma, CMO's /CDMO's and Europe Academic & Research Institutes
Job Profiles: Business Development, Marketing & Sales
Limited Super
GBP 850
*END-USER PRICING IS APPLICABLE to :
Company Profiles: Local Biopharma and BIG Pharma, Europe Academic & Research Institutes
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
Limited Super
GBP 2,050
*SOLUTION PROVIDER PRICING IS APPLICABLE to
Company Profile: Service & Solution Providers, Europe/UK and International biopharma, CMO's /CDMO's and Europe Academic & Research Institutes
Job Profiles: Business Development, Marketing & Sales
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2024 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.